Dr Kathryn Fox is an Australian medical doctor and bestselling crime writer, best known for her forensic thrillers featuring ...
Morning Overview on MSN
Animal muscle power sparks new biomaterials for farming, fashion & future medicine
Engineers at Washington University in St. Louis have developed a new class of protein-based fibers modeled on the aligned ...
1don MSN
Cell signaling step sharpens understanding of how the body responds to exercise's energy demands
Researchers have investigated the role of a certain enzyme in regulating energy in muscle and exercise performance for ...
A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.
You’re relaxing on the sofa when suddenly your eyelid starts twitching. Or perhaps it’s a muscle in your arm, your leg, or your foot that begins to spasm – sometimes for a few seconds, sometimes for ...
This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...
News-Medical.Net on MSN
Identifying the core catalyst for muscle energy production
Researchers have investigated the role of a certain enzyme in regulating energy in muscle and exercise performance for decades, but a new study by Virginia Tech scientists has identified more ...
Today, Artimus Robotics has announced its newest generation of contracting HASEL actuators. Through continued improvements in material science and manufacturing processes, these new actuators deliver ...
The protein threshold for building muscle may be lower than you think.
Researchers have investigated the role of a certain enzyme in regulating energy in muscle and exercise performance for decades, but a new study by ...
Expedition 74 advances muscle, vein, and respiratory research aboard the International Space Station
Expedition 74 crew members conduct muscle, vein, and respiratory studies aboard the International Space Station to examine microgravity’s effects on blood flow, exercise response, and cardiovascular ...
Gubra today announces that a clinical trial application (CTA) for the first-in-human study of GUB-UCN2, the company's lead asset for high quality weight loss, has been submitted to the Competent Autho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results